Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free
OncoCyte Corporation Common Stock AMEX OCX
$2.48 0.0000 0.0000%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 28 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

20.49M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
11.72M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.91
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
8.26M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-0.80 %
Upcoming events OncoCyte Corporation Common Stock All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart OncoCyte Corporation Common Stock

Stock analysis OncoCyte Corporation Common Stock

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.27 -0.83
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.80 1.95
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-1.53 -0.64
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
1.15 0.24
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-297.53 -87.14

Price change OncoCyte Corporation Common Stock per year

1.41$ 6.57$
Min Max

Summary analysis OncoCyte Corporation Common Stock

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure OncoCyte Corporation Common Stock

Revenue and net income OncoCyte Corporation Common Stock

All parameters
Stock news OncoCyte Corporation Common Stock All news

About company OncoCyte Corporation Common Stock

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides custom drug target discovery; assay design, development, and validation; and clinical trial and other testing services for pharmaceutical companies. OncoCyte Corporation has a strategic collaboration with Gruppo Oncologico del Nord-Ovest of Pisa to evaluate DetermaIO as a biomarker for immunotherapy response in metastatic colorectal cancer; and Echelon Diagnostics, Inc. The company was founded in 2009 and is headquartered in Irvine, California.
Address:
15 Cushing, Irvine, CA, United States, 92618
Company name: OncoCyte Corporation Common Stock
Issuer ticker: OCX
ISIN: US68235C1071
Country: USA
Exchange: AMEX
Currency: $
IPO date: 2016-01-04
Sector: Healthcare
Industry: Biotechnology
Site: https://oncocyte.com

On which stock exchange are OncoCyte Corporation Common Stock (OCX) stocks traded?

OncoCyte Corporation Common Stock (OCX) stocks are traded on AMEX.

What is the ticker of OncoCyte Corporation Common Stock stocks (OCX)?

The stock ticker of OncoCyte Corporation Common Stock’s stocks or in other words, the code is OCX. The stocks are currently listed on the AMEX exchange.

In which sector and industry does OncoCyte Corporation Common Stock (OCX) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, OncoCyte Corporation Common Stock (OCX) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are OncoCyte Corporation Common Stock (OCX) stocks traded?

OncoCyte Corporation Common Stock (OCX) stocks are traded on the AMEX exchange in dollars.

What is the price of OncoCyte Corporation Common Stock (OCX) stocks today?

The current price of OncoCyte Corporation Common Stock stocks on 27.04.2024 is 2.48 dollars. per share.

What is the dynamics of OncoCyte Corporation Common Stock (OCX) stocks from the beginning of the year?

OncoCyte Corporation Common Stock (OCX) quotes have increased by -24.85% from the beginning of the year up to 2.48 dollars. per 1 stocks.

How much did OncoCyte Corporation Common Stock (OCX) stocks increase in апреле 2024?

This month OncoCyte Corporation Common Stock (OCX) quotes have increased by -16.78% to 2.48 dollars. per share.

How much are OncoCyte Corporation Common Stock (OCX) stocks worth?

Today, on October, 27.04.2024 OncoCyte Corporation Common Stock’s (OCX) stocks cost 2.48 dollars..

What is the market capitalization of OncoCyte Corporation Common Stock (OCX)?

Capitalization is the market value of OncoCyte Corporation Common Stock (OCX) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 27.04.2024, the market capitalization of OncoCyte Corporation Common Stock (OCX) is estimated at about 20487461 dollars.